Considering a cellular laboratory viewpoint, Relafen 750 (Naproxen) exhibits particular characteristics . It operates primarily as a cyclooxygenase agent, largely blocking cyclooxygenase-2 (COX-2), an catalyst participating in prostaglandin production . This focused inhibition leads to diminished inflammation and pain , delivering potential advanta